ARTICLE | Company News
EpiGenesis, Genta deal
July 30, 2001 7:00 AM UTC
GNTA non-exclusively licensed several patents to EpiGenesis covering methods, compositions and processes for in vitro and in vivo inhibition of protein synthesis by antisense oligonucleotides. GNTA wi...